Briacell Therapeutics -CW27BCTXWPreferred / convertible
13F holders, Q3 2025 (September 30)3holders −3
0new positions
3sold out
$0.03avg. 13F price*
At the end of Q3 2025, 3 institutions reported holding Briacell Therapeutics -CW27 (BCTXW) in their 13F filings, down 3 from Q2 2025. 0 opened new positions and 3 sold out. The largest holders were Redmond Asset Management, LLC ($2K), Two Sigma Securities, LLC ($575) and NFSG Corp ($32).
- Company
- Briacell Therapeutics -CW27
- CUSIP
- 10778Y112
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 3 | $3K |
All 13F filers, Q2 2025 → Q3 2025: 81,793 shares sold, net −81,793 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Redmond Asset Management, LLC | — | No change | 75,000 | $2K |
| Two Sigma Securities, LLC | — | Reduce -65.9% | 18,264 | $575 |
| NFSG Corp | — | No change | 1,000 | $32 |
"% of holder's portfolio" is BCTXW's weight in each manager's 13F, not the share of Briacell Therapeutics -CW27 the manager owns.